Fundraising FoxVentiRx Pharmaceuticals
Seattle, US · 2 known investors
Find your way into VentiRx Pharmaceuticals
Sign up to see every warm intro you have to VentiRx Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the VentiRx Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RM
Robert M. Hershberg, M.D., Ph.D.Founder
KF
Kathleen FanningExecutive
Board
SG
Steven Gillis, Ph.D.Board director
AS
Atul SaranBoard director
PH
Patrick HeronBoard director
RL
Ron LauferBoard director
NV
Nicole VitulloBoard director
KS
Kent SnyderBoard director
Investors · 2
Frazier Life Scienceslisted by Frazier Life SciencesPalo Alto
How we know: Frazier Life Sciences's portfolio page · Not right? Tell us
Domain AssociatesreportedPrinceton · $200K – $15M
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$65.6M disclosed across 2 rounds · 2010–2014
▶$15MraisedSep 2014 · 1 investors · BiotechnologyRule 506(b)
▶$15MraisedSep 2014 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ron LauferDirector
- Atul SaranDirector
- Kathleen FanningExecutive Officer
- Robert M. Hershberg, M.D., Ph.D.Executive Officer, Director
- Kent SnyderDirector
- Steven Gillis, Ph.D.Director
- Patrick HeronDirector
- Nicole VitulloDirector
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$50.6MraisedSep 2014 · 9 investors · BiotechnologyRule 506(b)
▶$50.6MraisedSep 2014 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kathleen FanningExecutive Officer
- Steven Gillis, Ph.D.Director
- Atul SaranDirector
- Patrick HeronDirector
- Robert M. Hershberg, M.D., Ph.D.Executive Officer, Director
- Ron LauferDirector
- Nicole VitulloDirector
- Kent SnyderDirector
- Offering amount
- $53.1M
- Amount sold
- $50.6M
- First sale
- Jan 2010
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded VentiRx Pharmaceuticals?
- VentiRx Pharmaceuticals was founded by Robert M. Hershberg, M.D., Ph.D..
- Who are VentiRx Pharmaceuticals's investors?
- VentiRx Pharmaceuticals's investors include Frazier Life Sciences, Domain Associates.
- How much funding has VentiRx Pharmaceuticals raised?
- VentiRx Pharmaceuticals has disclosed $65.6M raised across 2 rounds.
- Where is VentiRx Pharmaceuticals headquartered?
- VentiRx Pharmaceuticals is headquartered in Seattle, US.